Forskning
Udskriv Udskriv
Switch language
Bispebjerg Hospital - en del af Københavns Universitetshospital
Udgivet

Acute changes in plasma glucose increases left ventricular systolic function in insulin-treated patients with type 2 diabetes and controls

Publikation: Bidrag til tidsskriftTidsskriftartikelpeer review

DOI

  1. Short-term mortality following tramadol poisonings in Denmark

    Publikation: Bidrag til tidsskriftTidsskriftartikelpeer review

  2. Drug use in patients with short bowel syndrome and intestinal failure

    Publikation: Bidrag til tidsskriftTidsskriftartikelpeer review

  3. VEuPathDB: the eukaryotic pathogen, vector and host bioinformatics resource center

    Publikation: Bidrag til tidsskriftTidsskriftartikelpeer review

  4. Glucagon Clearance is Preserved in Type 2 Diabetes

    Publikation: Bidrag til tidsskriftTidsskriftartikelpeer review

  • Andreas Andersen
  • Peter G Jørgensen
  • Jonatan I Bagger
  • Maria P A Baldassarre
  • Mikkel B Christensen
  • Ulrik Pedersen-Bjergaard
  • Tommi B Lindhardt
  • Gunnar Gislason
  • Filip K Knop
  • Tina Vilsbøll
Vis graf over relationer

Aims: We aimed to evaluate the effect of acute hyperglycaemia and hypoglycaemia on cardiac function in patients with type 2 diabetes (T2D) and a control group. Materials and methods: In a nonrandomized interventional study, insulin-treated patients with T2D (N = 21, mean ± SD age 62.8 ± 6.5 years, body mass index [BMI] 29.0 ± 4.2 kg/m 2, glycated haemoglobin [HbA1c] 51.0 ± 5.4 mmol/mol [6.8 ± 0.5%]) and matched controls (N = 21, mean ± SD age 62.2 ± 8.3 years, BMI 29.2 ± 3.5 kg/m 2, HbA1c 34.3 ± 3.3 mmol/L [5.3 ± 0.3%]) underwent one experimental day with plasma glucose (PG) clamped at three different 30-minute steady-state levels: (1) fasting plasma glucose (FPG); (2) hyperglycaemia (FPG + 10 mmol/L); and (3) hyperinsulinaemic hypoglycaemia (PG <3.0 mmol/L). Cardiac function was evaluated during each steady state by echocardiography. Results: Acute hyperglycaemia increased left ventricular (LV) ejection fraction from baseline in patients with T2D (mean [95% confidence interval] 4.5 percentage points [1.1; 7.9]) but not in controls (2.0 percentage points [−1.4; 5.4]). Mitral annular peak systolic velocity (s′) increased during hyperglycaemia in both patients and controls (0.4 m/s [0.2;0.6] and 0.6 m/s [0.4; 0.8], respectively), whereas global longitudinal strain rate only increased in the controls (−0.05 s −1 [−0.12; 0.02] and −0.11 s −1 [−0.18; −0.03], respectively). All measures of LV systolic function increased markedly during hypoglycaemia (P <0.01 for all). No interaction between group and PG level on cardiac function was observed. Conclusions: Acute hyperglycaemia and hypoglycaemia increase LV systolic function, with no difference between patients with T2D and controls. Standardization of PG may improve reproducibility when evaluating LV systolic function in patients with T2D.

OriginalsprogEngelsk
TidsskriftDiabetes, Obesity and Metabolism
Vol/bind24
Udgave nummer6
Sider (fra-til)1123-1131
ISSN1462-8902
DOI
StatusUdgivet - 2022

Bibliografisk note

© 2022 The Authors. Diabetes, Obesity and Metabolism published by John Wiley & Sons Ltd.

ID: 75977221